New Zealand - English - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - tyloxapol 0.25% - eye drops, solution - 0.25 % - active: tyloxapol 0.25% excipient: benzalkonium chloride boric acid dibasic sodium phosphate hypromellose purified water

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; hydrochloric acid; citric acid monohydrate; purified water; sodium chloride; sodium hydroxide - ganfort pf 0.3/5 eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - gentamicin sulfate, quantity: 3 mg/ml (equivalent: gentamicin, qty 3 mg/ml) - eye drops, solution - excipient ingredients: polyvinyl alcohol; dibasic sodium phosphate heptahydrate; sodium chloride; disodium edetate; benzalkonium chloride; sodium hydroxide; purified water; hydrochloric acid - gentopic eye drops are indicated in the topical treatment of infections of the external eye and its adnexa caused by susceptible bacteria. such infections include conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivits, acute meibomianitis and dacryocystitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops - excipient ingredients: sodium hydroxide; benzalkonium chloride; citric acid monohydrate; hydrochloric acid; dibasic sodium phosphate heptahydrate; purified water; sodium chloride - bimatoprost eye drops are indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; sodium hydroxide; dibasic sodium phosphate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: purified water; benzalkonium chloride; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops - excipient ingredients: water for injections; benzalkonium chloride; hyetellose; mannitol; sodium citrate dihydrate; sodium hydroxide - trusamide eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - atropine sulfate monohydrate, quantity: 0.1027 mg/ml (equivalent: atropine sulfate, qty 0.1 mg/ml) - eye drops, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - eikance 0.01% is indicated as a treatment to slow the progression of myopia in children aged from 4 to 14 years. atropine treatment may be initiated in children when myopia progresses greater than or equal to -1.0 d per year.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - travoprost 40 µg/ml;   - eye drops, solution - 40 mcg/ml - active: travoprost 40 µg/ml   excipient: benzalkonium chloride boric acid disodium edetate dihydrate hydrochloric acid mannitol polyethylene glycol hydrogenated castor oil purified water sodium hydroxide trometamol - travatan eye drops are indicated to decrease elevated intraocular pressure in: · ocular hypertension · open-angle glaucoma as monotherapy or as adjunctive therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ciclosporin, quantity: 1 mg/ml - eye drops, emulsion - excipient ingredients: medium chain triglycerides; cetalkonium chloride; glycerol; tyloxapol; poloxamer; sodium hydroxide; water for injections - treatment of severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes.